Skip to content
Screener

AngioDynamics ANGO Q4 2025 Annual earnings

Reported July 15, 2025 · Before market open

Revenue$80.2MBeat by $5.9M
EPS-$0.03Beat by $0.10
Revenue estimate$74.3M
EPS estimate-$0.13

Next report

Oct 8, 2026 (In 5 days)
Revenue estimate$80.5M
EPS estimate-$0.11

Financials

Q4 2025

Income statement

See full
Revenue$80.2M+12.9%
Gross profit$42.2M+9.6%
Operating income-$5.8M+59.9%
Net income-$6.1M+55.0%
EPS (diluted)-$0.15+54.5%

Balance sheet

See full
Cash & equivalents$55.9M-26.5%
Total debt$10.1M+71.6%
Total equity$183.0M-11.0%
Total assets$280.1M-11.8%

Cash flow

See full
CapEx$777.0K+37.3%

Valuation & ratios

Valuation

as of 05/31/25
See full
Market cap$394.29M+56.0%
Enterprise value$348.55M+90.9%
P/S1.3×+0.5×

Profitability

See full
Gross margin53.9%+3.0pp
Operating margin-13.7%-6.0pp
Net margin-11.6%-5.2pp

Returns & leverage

See full
Return on equity-17.5%-7.3pp
Debt / equity0.1×0.0×
Current ratio2.2×+0.1×

FAQ

When did AngioDynamics report Q4 2025 earnings?
AngioDynamics (ANGO) reported Q4 2025 earnings on July 15, 2025 before market open.
What were AngioDynamics's Q4 2025 revenue and EPS?
AngioDynamics reported revenue of $80.2M and eps of $-0.03 for Q4 2025.
Did AngioDynamics beat estimates in Q4 2025?
Revenue beat the consensus estimate of $74.3M by $5.9M. EPS beat the consensus estimate of $-0.13 by $0.10.
How did AngioDynamics's Q4 2025 results compare year-over-year?
Compared to the same quarter a year prior, revenue grew 12.9% from $71.0M a year earlier and eps grew 50.0% from $-0.06.
Where can I find AngioDynamics's Q4 2025 SEC filings?
You can read the 8-K earnings release (0001140361-25-025835) and the 10-K periodic report (0001275187-25-000014) directly on SEC EDGAR. The filing index links above go to sec.gov.